PPI Medications (like Omeprazole) and Research on Adverse Effects Researchers at Swedens Karolinska Institute and other institutions in Denmark, Finland, Iceland, and Norway found no association between long-term proton pump inhibitor (PPI) use and stomach cancer
After excluding individuals with pre-existing neurodegenerative or cerebrovascular disease, the study compared 30,430 patients using GLP-1RA therapy (semaglutide or tirzepatide) with 30,430 patients prescribed other antidiabetic agentsincluding biguanides, sulfonylureas, dipeptidyl peptidase 4 inhibitors, and sodium-glucose cotransporter 2 inhibitorsusing propensity score matching to control for baseline differences
Pharmacy Times and GoodRx reporting on the compounded GLP-1 wind-down
Important: Do not use if pregnant, breastfeeding, allergic to glutathione, or sensitive to related ingredients
Decision Framework: Questions to Ask Any Provider Rather than identifying a "best" option, individuals considering semaglutide treatment should evaluate their circumstances using these questions: Medical Appropriateness Do I have any contraindications listed in prescribing information